Why Sonova’s strong earnings have not yet changed its U.S. market perception
New York, USA, 23 February 2026 – Sonova recently delivered a surprise that...
Why outsourcing, new technologies, and supply chain resilience are reshaping the future of active pharmaceutical ingredients
New York, United States, 5 February 2026 - Active...
A major collaboration aims to expand access to immuno-oncology treatments as FYB206 moves toward FDA submission.
Mumbai, India, 10 December 2025 – Zydus Lifesciences has...
Ganaplacide lumefantrine combination delivers cure rates above WHO standards, offering new hope against growing artemisinin resistance.
London, 13 November 2025 – A major step forward...
Robust revenue expansion, higher profitability, strategic acquisitions, and new product launches position Zydus for a strong year ahead.
Sheridan, WY, 13 November 2025 – Zydus...
